Skip to main content

Tango Therapeutics, Inc 10-Q for FY2024 Q1

Tango Therapeutics, Inc. (TNGX)

10-Q 2024-05-08 For: 2024-03-31
View Original
Added on April 08, 2026

About this 10-Q

Tango Therapeutics, Inc filed this 10-Q on May 8, 2024, covering the quarter ended March 31, 2024 (FY2024 Q1).

Headline figures

Quarter ended March 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$6.47M
up 12.2% from $5.77M a year earlier
Net loss
$37.91M
compared with a net loss of $28.01M a year earlier
Diluted EPS
-$0.35
compared with -$0.32 a year earlier